Altaris Capital to acquire the health business of Johnson Matthey for $432m.

Altaris Capital, a healthcare investment firm, agreed to acquire the health business of Johnson Matthey, a sustainable technologies company, for $432m. JM will retain approximately 30% equity stake in the business. “As the world transitions to more sustainable technologies, we are focusing our portfolio on the most attractive growth areas, specifically businesses driving growth from climate change solutions – circularity solutions, hydrogen technologies and decarbonisation of chemicals and fuels. The sale of Health is a further step towards simplifying our portfolio," Robert MacLeod, JM CEO.